BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

414 hedge funds and large institutions have $14B invested in BioMarin Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 159 increasing their positions, 150 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
414
Holders Change
-8
Holders Change %
-1.9%
% of All Funds
10.37%
Holding in Top 10
11
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-15.38%
% of All Funds
0.28%
New
57
Increased
159
Reduced
150
Closed
57
Calls
$90.6M
Puts
$95.7M
Net Calls
-$5.06M
Net Calls Change
-$8.09M

Top Buyers

1
MNA
1
Manning & Napier Advisors
New York
$168M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.09B
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$116M
4
Primecap Management
4
Primecap Management
California
$653M
5
HM
5
HealthCor Management
New York
$64.2M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$98.7M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$736M
3
Sands Capital Management
3
Sands Capital Management
Virginia
$777M
4
Capital Research Global Investors
4
Capital Research Global Investors
California
$1.63B
5
FAM
5
Fred Alger Management
New York
$89.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
O
26
OrbiMed
New York
$106M +$10.1M +122,200 +11%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$103M +$9.16M +110,575 +10%
TCIM
28
TIAA CREF Investment Management
New York
$101M -$13.5M -163,529 -12%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$98.7M -$116M -1,395,706 -54%
WRF
30
Waddell & Reed Financial
Kansas
$95.6M -$1.95M -23,522 -2%
William Blair Investment Management
31
William Blair Investment Management
Illinois
$91.8M -$5.62M -67,834 -6%
TG
32
TCW Group
California
$90.6M -$4.63M -55,844 -5%
BG
33
BlackRock Group
United Kingdom
$90.4M +$4.27M +51,530 +5%
FAM
34
Fred Alger Management
New York
$89.9M -$46.4M -559,696 -34%
PHS
35
PFM Health Sciences
California
$87.6M +$27.7M +334,821 +46%
Northern Trust
36
Northern Trust
Illinois
$86.1M -$21.1M -254,800 -20%
Norges Bank
37
Norges Bank
Norway
$84M +$2.16M +26,046 +3%
PAMU
38
Pictet Asset Management (UK)
United Kingdom
$82.8M +$8.65M +104,362 +12%
UBS AM
39
UBS AM
Illinois
$81M -$8.58M -103,601 -10%
Massachusetts Financial Services
40
Massachusetts Financial Services
Massachusetts
$72.5M +$4.98M +60,152 +7%
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
$72.3M +$5.34M +64,453 +8%
ClearBridge Investments
42
ClearBridge Investments
New York
$67.6M +$7.53M +90,850 +13%
SIG
43
Senator Investment Group
New York
$66.3M -$4.14M -50,000 -6%
FCM
44
Frontier Capital Management
Massachusetts
$64.6M +$6.6M +79,664 +11%
HM
45
HealthCor Management
New York
$64.2M +$64.2M +775,000 New
PI
46
Putnam Investments
Massachusetts
$59.6M +$7.77M +93,762 +15%
Citadel Advisors
47
Citadel Advisors
Florida
$58M -$22.6M -272,548 -28%
Adage Capital Partners
48
Adage Capital Partners
Massachusetts
$55.5M +$3.73M +45,000 +7%
Legal & General Group
49
Legal & General Group
United Kingdom
$55.5M +$2.11M +25,512 +4%
CC
50
Carlson Capital
Texas
$53M +$53M +640,367 New
1
2
3 4 5